Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta‐Epidemiological Study
Journal of Evidence-Based Medicine · 2026-03 · 19 (1)
DOI: 10.1111/jebm.70115 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 31.01.2026. Verfasst von Claire Chenwen Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Medicine Development Fund of the Hong Kong SAR.
Abstract (Originalsprache)
Aim
In traditional Chinese medicine, different dosage forms of orally administered Chinese herbal medicine (CHM) may introduce bias in estimating treatment and adverse effects. This meta‐epidemiological study aimed to evaluate whether the use of different orally administered CHM dosage forms is associated with overestimation or underestimation of treatment and adverse effects in randomized controlled trials (RCTs).
Methods
Seven electronic databases were searched to identify potentially eligible meta‐analyses (MAs) of RCTs evaluating CHM interventions. A two‐step meta‐epidemiological analysis was performed, using ratios of odds ratios for binary outcomes and differences in standardized mean differences for continuous outcomes. These metrics assessed whether different orally administered CHM dosage forms—including CHM decoctions, Chinese patent medicines (CPMs), and CHM granules influenced the magnitude of reported treatment effects or adverse effects.
Results
Eighty‐two MAs comprising 1263 RCTs were analyzed. Overall, there was no consistent evidence that any oral dosage form systematically overestimated or underestimated treatment effects or adverse effects. Sensitivity analyses confirmed these findings, with the exception that CHM decoctions showed slightly larger binary treatment effects compared to CPMs after adjusting for incomplete outcome data. However, when adjusted for all confounders, CPMs yielded significantly greater continuous treatment effects than CHM decoctions. Additionally, CHM granules were associated with larger continuous treatment effects than CHM decoctions after adjusting for RCT funding. Subgroup analyses indicated that RCTs on digestive diseases tended to report larger effect estimates when using CHM decoctions, whereas RCTs on endocrine, nutritional, and metabolic diseases tended to report larger effect estimates when using CPMs.
Conclusions
This meta‐epidemiological study suggests that while oral dosage forms of CHM are associated with minimal differences in reported treatment and adverse effect estimates, specific dosage forms may offer advantages in certain contexts. Subgroup analyses indicate that digestive disease trials tend to report larger estimates with CHM decoctions, and endocrine/metabolic disease trials with CPMs. When adjusting for confounders, CPMs yield greater continuous treatment effects compared with CHM decoctions, while CHM granules are associated with larger estimates than CHM decoctions after adjusting for RCT funding. Further research is needed to confirm their clinical relevance and guide formulation choices in CHM practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
- Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
ORCID-Profile: Claire Chenwen Zhong, Mary Yue Jiang
Förderung
- Chinese Medicine Development Fund of the Hong Kong SAR
Zitieren
APA
Zhong, C. C., Wang, B. H., Jiang, M. Y., Ho, L., Ho, F. F., Wu, I. X. Y., Cheung, Y. T., & Chung, V. C. H. (2026). Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta‐Epidemiological Study. Journal of Evidence-Based Medicine, 19(1). https://doi.org/10.1111/jebm.70115
Vancouver
Zhong CC, Wang BH, Jiang MY, Ho L, Ho FF, Wu IXY, et al. Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta‐Epidemiological Study. Journal of Evidence-Based Medicine. 2026;19(1). doi:10.1111/jebm.70115
BibTeX
@article{Zhong2026,
author = {Zhong, Claire Chenwen and Wang, Betty Huan and Jiang, Mary Yue and Ho, Leonard and Ho, Fai Fai and Wu, Irene Xin Yin and Cheung, Yin Ting and Chung, Vincent Chi Ho},
title = {Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta‐Epidemiological Study},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
volume = {19},
number = {1},
doi = {10.1111/jebm.70115}
}
EUVIMED